| Futibatinib studied in …STUDIED_INderived21 of 21show fewer |
|---|
| → studied in | NCT02693535Phase 2 · recruiting TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer · 21 trials list this drug (12 active) | — | — | Solid Neoplasm,Multiple Myeloma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05727176Phase 2 · recruiting Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement · 21 trials list this drug (12 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05945823Phase 2 · active not recruiting Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors · 21 trials list this drug (12 active) | — | — | Malignant Pancreatic Neoplasm,Esophageal Squamous Cell Carcinoma,Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05827614Phase 1 · terminated Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications · 21 trials list this drug (12 active) | — | — | Cervical Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma,Leiomyosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04999761Phase 1 · recruiting AB122 Platform Study · 21 trials list this drug (12 active) | — | — | Malignant Head and Neck Neoplasm,Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07745296Phase 3 · not yet recruiting Investigating Precision Medicine in the Adjuvant Setting in Biliary Tract Cancer · 21 trials list this drug (12 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06506955Phase 2/Phase 3 · active not recruiting Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy. · 21 trials list this drug (12 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07710885Phase 3 · recruiting Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer · 21 trials list this drug (12 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02813135Phase 1/Phase 2 · recruiting European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors · 21 trials list this drug (12 active) | — | — | Childhood Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05615818Phase 3 · recruiting Personalized Medicine for Advanced Biliary Cancer Patients · 21 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07594548Phase 1 · not yet recruiting Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma · 21 trials list this drug (12 active) | — | — | Esophageal Adenocarcinoma,Gastric Adenocarcinoma,Gastroesophageal Junction Adenocarcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03784014Phase 3 · completed Molecular Profiling of Advanced Soft-tissue Sarcomas · 21 trials list this drug (12 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05036681Phase 2 · terminated A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma · 21 trials list this drug (12 active) | — | — | Malignant Neoplasm,Endometrial Carcinoma,Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04507503approved for marketing Expanded Access Study of TAS-120 in Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements · 21 trials list this drug (12 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04601857Phase 2 · terminated Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma · 21 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06263153Phase 2 · recruiting Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy · 21 trials list this drug (12 active) | — | — | Bladder Urothelial Carcinoma,Malignant Bladder Neoplasm,Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04828486Phase 2 · completed Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer · 21 trials list this drug (12 active) | — | — | Hepatocellular Carcinoma,BCLC Stage A Hepatocellular Carcinoma,BCLC Stage B Hepatocellular Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04024436Phase 2 · terminated A Study of TAS-120 in Patients With Metastatic Breast Cancer · 21 trials list this drug (12 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04189445Phase 2 · terminated Futibatinib in Patients With Specific FGFR Aberrations · 21 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02052778Phase 1/Phase 2 · completed A Study of TAS-120 in Patients With Advanced Solid Tumors · 21 trials list this drug (12 active) | — | — | Malignant Breast Neoplasm,Malignant Gastric Neoplasm,Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03767075Phase 2 · recruiting A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets) · 21 trials list this drug (12 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |